National institute of biomedical imaging and bioengineering (nibib) HIV/aids radx innovation funnel
Ended Awarded Last action
- Contract number
- 75N92022F00002
- Awardee
-
The General Hospital Corporation UEI FLJ7DQKLL226
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $298,795
Award facts
- Opportunity
-
- National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation Pre-Solicitation · 75N92022R0114 · Posted May 26, 2022
- Contract value 100% obligated
- $298,795.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541614 Process, Physical Distribution, and Logistics Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Winter Hill, MA 02145, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $298,795 |
About this award
The National Institute of Biomedical Imaging and Bioengineering awarded a delivery order valued at $298,795.32 to Massachusetts General Hospital (doing business as The General Hospital Corporation) on September 1, 2022, with an ultimate completion date of August 31, 2024. This firm fixed-price contract, which was not set aside for any specific business category, supports the HIV/AIDS RADX Innovation Funnel initiative and will be performed at the contractor's Winter Hill location in Boston, Massachusetts. While the funding is administered through the National Heart Lung and Blood Institute, the work aligns with NIBIB's mission to advance biomedical imaging and bioengineering technologies relevant to infectious disease research and treatment innovation.
Massachusetts General Hospital, a prominent nonprofit academic medical center and Harvard Medical School teaching hospital, brings substantial federal research capabilities to this engagement. As a major recipient of NIH funding and holder of a $25 million blanket purchase agreement with the Defense Advanced Research Projects Agency, MGH has demonstrated expertise across diverse biomedical research domains including infectious diseases, translational research, and advanced medical technology development. Under this delivery order, MGH will contribute its established research infrastructure and scientific expertise to accelerate innovation in HIV/AIDS diagnostic, therapeutic, and preventive technologies through the RADX program's structured innovation funnel approach.
Quick answers
Who was awarded contract 75N92022F00002?
75N92022F00002 was awarded to The General Hospital Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2022.
How much is contract 75N92022F00002 worth?
The government has obligated $298,795 on 75N92022F00002.
Is contract 75N92022F00002 an order under another contract?
Yes. 75N92022F00002 is a delivery order under 75N92022D00014, an indefinite delivery contract.
Was contract 75N92022F00002 competed?
The extent of competition for 75N92022F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award